Search

everythinglearnresearchcommunity

for

Search:↓

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

ATP increases melanin production in skin after UV exposure, with the P2X7 receptor being crucial for this process.

IGFBP-rP1 could be a new treatment for a common type of hair loss.

Androgenetic alopecia, a genetic disorder affecting up to 50% of adults, is caused by an excessive response to androgens leading to hair follicle shrinkage. Treatments include FDA-approved drugs, other therapies like low-dose oral minoxidil, and hair transplantation.

TRPM5 is crucial for maintaining hair growth.

TAF4 is important for skin cell growth and helps prevent skin cancer in mice.

The US and EU lead in cell and gene therapy regulations with more approvals and clinical trials, while India is in early stages with fewer approvals and expedited processes.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

Palmitoyl tetrapeptide-20 may help reduce hair greying and increase melanin production.

Ku80 is a key receptor for Thymosin β4, affecting cell migration and wound healing.

Overexpressing SSAT in mice makes them highly sensitive to polyamine analogues, causing liver damage and high mortality.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Botulinum toxin may help hair loss by increasing blood flow and reducing harmful factors.

A boy's growth and immune problems were caused by a new mutation in the STAT5B gene.

The role of γδT-cells in causing alopecia areata remains unclear.

A new small peptide may help hair growth by activating a specific receptor and should be tested in humans.

CircAGK affects cell death in hair cells by controlling the miR-3180-5p/BAX pathway, which can lead to hair loss.

Found new possible treatments for hair loss.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

The visfatin GT genotype may increase the risk of Alopecia Areata.

Ayme-Gripp Syndrome was confirmed in a woman through genetic testing, highlighting the need to consider rare genetic conditions in diagnoses.

Promising cancer treatments were found, but the manufacturer closed.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Phospholipids help plant proteins move by regulating receptor interactions.

Blocking DGAT1 reduces oil gland size in mice and dogs, but only mice experience hair loss.

A woman experienced severe side effects from a drug due to a specific genetic variation, suggesting genetic testing could prevent such risks.

The study found two new mutations in a Chinese patient with severe biotinidase deficiency.

NCBP3, SDHA, and PTPRA are the best genes for accurate goat skin research.

Combining ATRA with TPO-RA effectively stabilizes platelet counts in ITP patients.